CLVLF (CLVLF) Stock Price & Analysis
CLVLF (CLVLF) rose 0.00% to USD 6.1 as of July 26, 2026 at 09:43 UTC, according to Nexqual real-time market data.
CLVLF last closed at USD 6.1; the session ranged USD 6.1–6.1 on volume of 1,500 shares. Market capitalization is —, with a 52-week range of USD 6.1–8.6 (PNK). Source: Nexqual, July 26, 2026 at 09:43 UTC.
Key Statistics (as of July 26, 2026 at 09:43 UTC)
| Price | USD 6.1 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 6.1 |
| Open | USD 6.1 |
| Day Range | USD 6.1 – 6.1 |
| 52-Week Range | USD 6.1 – 8.6 |
| Volume | 1,500 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (CLVLF)
Nexqual's technical model rates CLVLF "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 26, 2026 at 09:43 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 0 (oversold) |
| vs SMA50 | Below (USD 6.28) |
| MACD | -0.04 (negative) |
Financial Health Score (CLVLF)
Nexqual rates CLVLF's overall financial health "Strong" across five dimensions, as of July 26, 2026 at 09:43 UTC.
| Growth | Solid — Revenue +8% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 90%, operating 37% |
| Balance Sheet | Strong — $233M cash, no debt |
| Cash Flow | Strong — FCF $32M, 34% margin |
| Efficiency | Mixed — ROE 14%, ROA 10.6% |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CUVL | Clinuvel Pharmaceuticals Limited American Depositary Shares | USD 6.95 | ▼ 0.71% |
| MLLCF | Molecular Partners AG | USD 3.8 | ▲ 0% |
| OXBDF | Oxford Biomedica PLC | USD 8 | ▲ 0.88% |
| CMXHF | CSL Ltd. | USD 81.96 | ▲ 0% |
| INRLF | Valneva SE | USD 2.62 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 09:43 UTC. This page is informational and not investment advice.